- Home
- INMD vs PEB Comparison
INMD vs PEB Comparison
Compare INMD & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- PEB
- Stock Information
- Founded
- INMD 2008
- PEB 2009
- Country
- INMD Israel
- PEB United States
- Employees
- INMD N/A
- PEB N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PEB Real Estate Investment Trusts
- Sector
- INMD Health Care
- PEB Real Estate
- Exchange
- INMD Nasdaq
- PEB Nasdaq
- Market Cap
- INMD 887.0M
- PEB 1.1B
- IPO Year
- INMD 2019
- PEB 2009
- Fundamental
- Price
- INMD $13.28
- PEB $9.52
- Analyst Decision
- INMD Hold
- PEB Hold
- Analyst Count
- INMD 6
- PEB 6
- Target Price
- INMD $17.56
- PEB $12.05
- AVG Volume (30 Days)
- INMD 1.1M
- PEB 2.3M
- Earning Date
- INMD 07-31-2025
- PEB 07-23-2025
- Dividend Yield
- INMD N/A
- PEB 0.42%
- EPS Growth
- INMD 8.69
- PEB N/A
- EPS
- INMD 2.29
- PEB N/A
- Revenue
- INMD $392,408,000.00
- PEB $1,459,506,000.00
- Revenue This Year
- INMD $0.16
- PEB $1.63
- Revenue Next Year
- INMD $4.84
- PEB $2.98
- P/E Ratio
- INMD $5.79
- PEB N/A
- Revenue Growth
- INMD N/A
- PEB 2.19
- 52 Week Low
- INMD $13.16
- PEB $7.42
- 52 Week High
- INMD $19.85
- PEB $15.12
- Technical
- Relative Strength Index (RSI)
- INMD 33.86
- PEB 51.45
- Support Level
- INMD $13.16
- PEB $8.88
- Resistance Level
- INMD $13.67
- PEB $10.03
- Average True Range (ATR)
- INMD 0.40
- PEB 0.34
- MACD
- INMD -0.09
- PEB 0.02
- Stochastic Oscillator
- INMD 7.23
- PEB 58.13
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.